[ad_1]
LONDON (Reuters) – British researchers yesterday announced that they were testing an effective way to diagnose cancer from patients' breathing. They added that they had developed a device called "respiratory biopsy" (on the biopsy pattern taken from suspected cancer tissue) to monitor volatile particles in the breath.
Researchers at the Yuche Cancer Research Foundation and the Olston Medical research group, who designed the new test, believe the device will make it easier to diagnose early-stage cancers and treat the disease quickly.
The test is designed to monitor volatile organic compounds that are released by the breath after being collected and sent to the laboratory for badysis. These compounds come from the cells of the body as part of the process of activity and work, they reach the lungs and are then expressed by breathing.
Scientists say the test aims to monitor trends in the presence of volatile vehicles, as well as any anomalies in these trends. To monitor, participants will be asked to breathe in the badyzer for 10 minutes.
On the other hand, an American medical research company announced that she was experimenting with pumping the blood of young people into the body of people with Parkinson's disease, which is causing the disease Parkinson's.
As part of the new tests, patients aged 70 to 80 years mainly enjoy a blood entitlement for 5 consecutive days, then another right after 3 months. The experiments will determine the usefulness of this treatment by monitoring the progress of memory, attention, language skills and cognitive abilities.
[ad_2]
Source link
